Gryphon Investors Acquires Metagenics from Alticor

Gryphon-Backed Metagenics Acquires UK Probiotic Brand Symprove

January 23, 2026

Consumer Products

Gryphon Investors-backed Metagenics has acquired Symprove, a UK-based probiotic brand, from bd-capital. The deal — terms undisclosed — was completed alongside a strategic debt recapitalization to provide Metagenics with additional capital for organic investment and future M&A; Symprove will continue to be led by CEO Will Bowler.

Equillium Acquires Metacrine in All-Stock Transaction

September 6, 2022

Biotechnology

Equillium, Inc. will acquire Metacrine Inc. in an all-stock merger intended to strengthen Equillium's cash position by adding an estimated $33 million at closing and extending its cash runway into 2024. The deal adds Metacrine's FXR platform, including lead candidate MET642, to Equillium's pipeline while Metacrine CEO Preston Klassen will join Equillium's board; closing is subject to shareholder approvals and customary conditions.

Gryphon Investors Acquires Vetnique Labs

April 20, 2023

Consumer Products

Gryphon Investors, a San Francisco-based private equity firm, has acquired Vetnique Labs, a Naperville, Illinois-based pet health and wellness company. Gryphon will partner with founder and CEO James Bascharon (who will remain in role and retain a significant stake) to expand Vetnique’s product portfolio and geographic reach; financial terms were not disclosed.

Deloitte Acquires Gryphon Scientific to Expand Biosecurity and Public Health Capabilities

April 29, 2024

Professional Services

Deloitte Consulting LLP has acquired substantially all of the assets of Gryphon Scientific, LLC, bringing Gryphon's multidisciplinary team of scientists, data scientists, and policy specialists into Deloitte's federal health and government services practice. The acquisition strengthens Deloitte's biosecurity, lab safety, AI-driven analytics, and emergency preparedness capabilities for government and commercial clients.

Hg Acquires Majority Stake in A-LIGN from Warburg Pincus

July 8, 2025

Cybersecurity

Hg has acquired a majority stake in A-LIGN from Warburg Pincus to support the cybersecurity compliance firm's next phase of global expansion. HgCapital Trust plc and other institutional clients of Hg (via the Hg Genesis Fund) are investing alongside Hg; terms were not disclosed. A-LIGN, headquartered in Tampa, Florida, is a tech-enabled cyber compliance and audit provider serving over 5,700 clients and will leverage Hg's resources to scale internationally and expand services.

H.I.G. Capital Acquires Taconic Biosciences

February 7, 2019

Healthcare Services

H.I.G. Capital, through an affiliate, has completed the acquisition of Taconic Biosciences, a global provider of genetically engineered research models and related services. The private equity investment will partner with Taconic's management to support geographic expansion, broaden product and service offerings, and accelerate M&A-driven growth.